Learn More
Medchemexpress LLC Enzalutamide-based VHL-recruiting androgen receptor degrader (ARCC-4) | 1973403-00-7 | MFCD32858266 | 99.9% | C53H56F3N7O7S2 | 10MG

Supplier: Medchemexpress LLC HY13049210MG
A potent proteolysis-targeting chimera (PROTAC) small molecule that induces targeted proteasomal degradation of the androgen receptor (AR). It demonstrates low-nanomolar degradation activity in cellular assays and is used to probe AR signaling and prostate cancer biology. Molecular formula C53H56F3N7O7S2; molecular weight 1024.18 Da.
- Low-nanomolar potency for androgen receptor degradation.
- Mechanism recruits VHL E3 ligase to promote proteasomal degradation.
- Effective against wild-type and clinically relevant AR mutants in cell models.
- High purity suitable for in vitro research applications.
- Available in multiple small-scale pack sizes and as a DMSO solution for convenience.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.